Matches in Wikidata for { <http://www.wikidata.org/entity/Q66387981> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66387981 description "clinical trial" @default.
- Q66387981 description "ensayu clínicu" @default.
- Q66387981 description "klinisch onderzoek" @default.
- Q66387981 description "клінічне випробування" @default.
- Q66387981 name "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy" @default.
- Q66387981 name "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy" @default.
- Q66387981 type Item @default.
- Q66387981 label "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy" @default.
- Q66387981 label "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy" @default.
- Q66387981 prefLabel "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy" @default.
- Q66387981 prefLabel "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy" @default.
- Q66387981 P1050 Q66387981-D5DE4483-05DE-439C-8A09-D373F0DF93B4 @default.
- Q66387981 P1050 Q66387981-F14DBFD5-7505-4B28-B7D2-D31A7BF4B524 @default.
- Q66387981 P1132 Q66387981-6EFDF0B7-5F0F-4D8F-8EB5-BC7B2F6F695F @default.
- Q66387981 P1476 Q66387981-8D1A2CA2-E0EB-431C-B50D-F2DA93B0A3A7 @default.
- Q66387981 P2899 Q66387981-5A27AFED-C463-44A8-8801-CAF609D4F19E @default.
- Q66387981 P3098 Q66387981-FC30849C-AA54-45D2-AD1C-43F80E36F62F @default.
- Q66387981 P31 Q66387981-F734421A-DFD5-4E97-8106-88AC709DD58C @default.
- Q66387981 P4135 Q66387981-C457B308-F31B-44B2-A2E8-E81256BB0BB8 @default.
- Q66387981 P580 Q66387981-0B5D78C7-E6DD-40BF-B69D-5B6DB6357D29 @default.
- Q66387981 P582 Q66387981-2E399CAE-091C-4267-8E04-411D2B6EDA0B @default.
- Q66387981 P6099 Q66387981-415CB86E-B664-4945-8EE8-D818C47828EA @default.
- Q66387981 P6099 Q66387981-601343DB-A151-47D0-880F-DF6B305348BE @default.
- Q66387981 P8363 Q66387981-1CB9D065-ECFA-4C10-9B7B-A3B38692311A @default.
- Q66387981 P1050 Q131742 @default.
- Q66387981 P1050 Q6853 @default.
- Q66387981 P1132 "+30" @default.
- Q66387981 P1476 "Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy: A Phase I/II Ascending Multiple Dose Study" @default.
- Q66387981 P2899 "+18" @default.
- Q66387981 P3098 "NCT04046107" @default.
- Q66387981 P31 Q30612 @default.
- Q66387981 P4135 "+70" @default.
- Q66387981 P580 "2019-10-07T00:00:00Z" @default.
- Q66387981 P582 "2023-04-30T00:00:00Z" @default.
- Q66387981 P6099 Q42824440 @default.
- Q66387981 P6099 Q5452194 @default.
- Q66387981 P8363 Q78089383 @default.